INVO Bioscience and NAYA Biosciences Close Merger, The Combined Company Expects To Change Its Name To Naya Biosciences And Trade On The Nasdaq Under The "NAYA" Ticker
Portfolio Pulse from Benzinga Newsdesk
INVO Bioscience has completed its merger with NAYA Biosciences. The combined entity will be renamed NAYA Biosciences and will trade on NASDAQ under the ticker 'NAYA'. The company will focus on fertility, oncology, and autoimmune diseases.
October 14, 2024 | 1:25 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
INVO Bioscience has merged with NAYA Biosciences, and the combined company will be renamed NAYA Biosciences, trading under the ticker 'NAYA'. This merger expands INVO's focus to include oncology and autoimmune diseases.
The merger with NAYA Biosciences is a significant strategic move for INVO Bioscience, expanding its business into oncology and autoimmune diseases. The change in ticker to 'NAYA' and the leadership structure suggests a strong commitment to this new direction, likely positively impacting the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100